Skip to main content
Cerebral Circulation - Cognition and Behavior logoLink to Cerebral Circulation - Cognition and Behavior
. 2023 Jan 17;4:100158. doi: 10.1016/j.cccb.2023.100158

Fornix degeneration in risk factors of Alzheimer's disease, possible trigger of cognitive decline

María Lacalle-Aurioles a,, Yasser Iturria-Medina a,b,c
PMCID: PMC9871745  PMID: 36703699

Highlights

  • Alzheimer's disease has a multifactorial etiology.

  • Cerebrovascular dysfunction and white matter inflammation are early factor in AD.

  • The fornix is highly vulnerable to vascular deficits and inflammation.

  • Fornix degeneration occurs in AD but also in risk factors of AD.

  • Fornix degeneration can facilitate dementia in populations at risk.

Keywords: White matter, Neuroinflammation, Cerebrovascular pathology, Blood-brain barrier, Diffusion tensor imaging, Galectin-3

Abbreviations: CVRFs, cardiovascular risk factors; DTI, difussion tensor imaging; NODDI, neurite orientation dispersion and density imaging; TBI, traumatic brain injury; WM, white matter

Abstract

Risk factors of late-onset Alzheimer's disease (AD) such as aging, type 2 diabetes, obesity, heart failure, and traumatic brain injury can facilitate the appearance of cognitive decline and dementia by triggering cerebrovascular pathology and neuroinflammation.

White matter (WM) microstructure and function are especially vulnerable to these conditions. Microstructural WM changes, assessed with diffusion weighted magnetic resonance imaging, can already be detected at preclinical stages of AD, and in the presence of the aforementioned risk factors. Particularly, the limbic system and cortico-cortical association WM tracts, which myelinate late during brain development, degenerate at the earliest stages. The fornix, a C-shaped WM tract that originates from the hippocampus, is one of the limbic tracts that shows early microstructural changes. Fornix integrity is necessary for ensuring an intact executive function and memory performance. Thus, a better understanding of the mechanisms that cause fornix degeneration is critical in the development of therapeutic strategies aiming to prevent cognitive decline in populations at risk. In this literature review, i) we deepen the idea that partial loss of forniceal integrity is an early event in AD, ii) we describe the role that common risk factors of AD can play in the degeneration of the fornix, and iii) we discuss some potential cellular and physiological mechanisms of WM degeneration in the scenario of cerebrovascular disease and inflammation.

1. Introduction

Late-onset Alzheimer's disease (AD) is the most common neurological disorder in aged populations and it is expanding rapidly due to an increased lifespan and, presumably, to changes in our life style [1,2]. Presence of cardiovascular risk factors (CVRFs) in midlife, the absence of physical exercise in our daily routine, or traumatic brain injuries (TBI) may facilitate the development of AD in the elderly, in part by triggering cerebrovascular disease and neuroinflammation [3,4].

White matter (WM) is known to be especially susceptible to vascular pathology, supposedly, due to a lower microvascular density and reduced blood supply compared to the gray matter [5], [6], [7]. Interestingly, in recent years, a growing body of literature proposes microstructural WM changes as one of the earliest events in late-onset AD [8,9]. Microstructural WM changes in AD patients are predominantly found in parietotemporal regions (cingulate and parahippocampal WM tracts), the limbic system (uncinate fasciculus and fornix), and some parts of the corpus callosum, especially in posterior regions such as the splenium [10], [11], [12], [13], [14], [15], [16]. Among these fibers, the limbic system and the cortico-cortical association tracts seem to be more vulnerable [17], [18], [19].

The fornix is the main inflow/outflow information pathway of the hippocampus, making it a key structure in learning and memory processes. Reduced forniceal integrity already appears at preclinical phases of AD (reviewed in Nowrangi and Rosenberg [20]) and under risk factors of AD: aging [21,22], obesity [23], [24], [25], type 2 diabetes [26], [27], [28], heart failure [29] or TBI [30,31]. However, it is still unknown whether fornix degeneration may facilitate cognitive decline in populations at risk of developing AD. Moreover, the cellular and physiological mechanisms involved in fornix degeneration remain elusive.

We performed a search in PubMed® database to select original research articles, case reports, and review papers reporting microstructural WM changes in the fornix among AD patients or subjects with CVRFs or TBI. Keywords used in the search included: “white matter”, “fornix”, “diffusion tensor imaging”, “type 2 diabetes”, “obesity”, “heart failure”, and “traumatic brain injury”. Additionally, a search for WM degeneration mechanisms included: “blood-brain barrier”, “white matter inflammation” and “Galectin-3″.

In this literature review, we deepen the idea of WM damage of the fornix as an early event in AD, and summarize the literature reporting forniceal damage in risk factors of AD. Finally, we describe key vascular and inflammatory mechanisms that can potentially trigger forniceal WM alterations and facilitate cognitive deficits.

2. Cerebrovascular pathology and white matter changes in Alzheimer's disease

AD has been traditionally considered a neurodegenerative disorder with amyloid-β (Aβ) plaques and neurofibrillary tangles (composed of hyperphosphorylated tau) as primary histological hallmarks. Since the early 1990s, the amyloid hypothesis has motivated the vast majority of clinical trials in AD [32], even though in 1984 it was accepted by the scientific community that a relevant vascular component contributes to AD [33].

Recently, the vascular component of AD has regained prominence. Epidemiological studies have associated some CVRFs (i.e., smoking, diabetes and obesity) with a higher incidence of AD and, presumably, clinical strategies focused on CVRF prevention could reduce the predicted prevalence of AD in the long term [34,35].

A compromised cerebrovascular function is now recognized as a critical event in the development of late-onset AD, with up to 80% of AD patients showing vascular pathology [5,[36], [37], [38], [39], [40], [41], [42]]. Moreover, causal multifactorial studies point to the vascular component as a disease triggering factor [43,44]. According to these studies, late-onset AD would be caused by the complex interplay among multifactorial interactions, not by a unique dominant biological factor (e.g., vascular or Aβ), and most-likely, the brain vasculature would be the initial pathologic event. Yet, the specific interplay between vascular and neuronal pathologies in AD is poorly understood.

In addition, neuroimaging studies of diffusion tensor imaging (DTI) have pointed to disrupted functional networks, due to microstructural WM changes, as a possible cause of the earliest cognitive impairments in AD patients.

In the WM, DTI studies rely on the highly ordered (anisotropic) water diffusion that results from the unique geometric organization of axonal fiber bundles. Changes in DTI parameters (e.g., axial diffusivity (AxD), radial diffusivity (RD), mean diffusivity (MD) and fractional anisotropy (FA)) refer to the altered anisotropy and/or diffusivity of water molecules caused by changes in the WM microstructure [45,46]. MD and FA are the most used parameters in AD studies. MD corresponds to the average water diffusion within the region of interest independent of the tissue direction. FA is the main parameter of anisotropic (directional) diffusion, with higher values reflecting increased directionality of diffusion, and mostly reflects the alignment of the cellular structures and the degree of axonal fiber bundle organization [47], [48], [49]. Several factors such as reduced fiber density, decreased myelination in fiber tracts, gliosis, inflammation, and ischemic processes can modulate the barriers to free water diffusion, reduce anisotropy and/or increase water diffusivity in the WM [50,51]. Although the specific causes for DTI parameter changes remain unclear, evidence that those changes occur early in AD supports the brain disconnection hypothesis in these patients [9,16,[52], [53], [54], [55], [56]]. According to this hypothesis, the partial loss of WM fiber integrity would contribute to the development of dementia by interfering with a proper signaling between interconnected brain regions [57], [58], [59]. A complex task such as memory retrieval requires the coordinated activity of functionally connected regions, thus, the partial disconnection of these regions could lead to a loss of function [60].

Interestingly, AD patients with a strong vascular component show more severe microstructural WM changes than those with a subtle vascular component [61], which suggest that WM integrity is highly susceptible to cerebrovascular deficits. Changes in water diffusivity at pre-symptomatic stages of AD can be assessed with DTI long before macrostructural WM changes, in the form of WM hyperintensities, can be detected with conventional magnetic resonance imaging (MRI), and before the presence of Aβ plaques and neurofibrillary tangles (reviewed in Sachdev et al. [58]). Moreover, more advanced and sensitive imaging techniques able to provide information about neurite microstructure (neurite orientation dispersion and density imaging (NODDI)) have detected microstructural WM changes in groups of preclinical AD patients in which DTI failed to find WM deficits [62].

The disconnection hypothesis has added one more level of complexity to the understanding of AD etiology but, on the other hand, comprehending the physiological mechanisms that trigger WM changes and the link with vascular pathology may shed light on the relationship between the cerebrovascular dysfunction seen in many risk factors of AD and the neurodegeneration finally leading to AD.

A better understanding of these mechanisms is also essential for novel therapies aiming to rescue dysfunctional brain circuits to succeed. Namely, deep brain stimulation of the fornix (DBS-f). DBS is a neurosurgical procedure able to modulate the activity of brain circuits through electrical stimulation delivered by electrodes that are implanted in target areas in the brain [63]. Neuromodulation of the fornix by DBS is currently under research for memory rescue in patients with AD [64]. However, even though initial stages of the clinical trial showed a certain delay in the progression of cognitive decline in AD patients, later results from more advanced stages of the trial have failed to confirm such benefits as a group effect and suggest benefits in only a subgroup of AD patients (i.e., ≥ 65 years) [65,66]. According to the authors, the inhomogeneity in functional and structural deficits between subjects could have been among the limiting factors of the study. For this reason, it is important to be able to efficiently identify the subpopulations of AD patients that can potentially benefit from this type of procedure.

3. Fornix anatomy and its role in learning and memory processes

The fornix is an arch-shaped WM structure located under the corpus callosum and above the thalamus (Fig. 1). It is composed of two symmetric bands (one per hemisphere) that are divided into three anteroposterior anatomical segments: columns, body and crura. The fornix connects the hippocampus with the diencephalon and the basal forebrain, and interconnects bilateral hippocampi across the hippocampal commissure [67]. In an anterograde pathway (septo-hippocampal pathway), the fornix carries the efferent axons of pyramidal cells in the subiculum and cornu ammonis 1 (CA1) and 3 (CA3) of the hippocampus. In a retrograde pathway, the fornix carries the afferent cholinergic, GABAergic and glutamatergic projections from the medial septum-diagonal band of Broca to the hippocampus, modulating the activity of neurons and interneurons [18,68,69].

Fig. 1.

Fig 1

Three-dimensional representation of the fornix of a healthy adult subject. Coronal (left), axial (center) and sagittal (right) views, overlapped on a T1-weighted magnetic resonance image. DSI studio software was used for visualization (dsi-studio.labsolver.org).

The interruption of this circuitry as a consequence of fornix degeneration in aging or pathological conditions is believed to impair executive function and episodic memory consolidation [70], [71], [72], [73], [74]. Most evidence for fornix degeneration triggering learning and memory deficits comes from experimental animal models or case studies reporting forniceal lesions caused by infarction, traumatic injuries, or tumors (reviewed in Senova et al., [69]). These reports indicate that different aspects of the fornix are involved in distinct memory functions [75], [76], [77]. Namely, verbal and visuospatial memory information are thought to be primarily carried by the left and the right fornix, respectively. Additionally, while emotional and motivational learning would be mainly processed by lateral regions of the fornix, the medial aspect of this structure would be responsible of integrating object recognition within a spatial context. Bilateral lesions of the anterior columns of the fornix can lead to anterograde and retrograde amnesia.

The specific mechanism by which fornix degeneration impairs cognition and memory in humans are poorly understood, especially because, in most cases, lesions of the fornix are accompanied with lesions in other brain regions that could also be involved in learning and memory (i.e., the medial temporal lobe or the mammillary bodies). But experimental animal models suggest dysregulation of the cholinergic and GABAergic signaling as possible factors [78], [79], [80]. These neurotransmitters are key as they modulate cortical and hippocampal neuronal activity.

The role of the fornix in memory recall has also been studied in healthy volunteers by using DTI [45]. In a study with healthy young adults, higher FA in the fornix correlated with better recollection in scene and object recognition tasks [81]. In another study with healthy subjects, higher FA in the fornix correlated with better performance in the Doors and People Test, which assesses verbal and visual recall and recognition [82].

4. Changes in fornix microstructure, an early event in AD

WM degeneration in AD has been explained by two different mechanisms: Wallerian degeneration and the retrogenesis model [17,83,84]. The hypothesis based on Wallerian degeneration assumes secondary axonal damage following cortical neurodegeneration, but considering that the literature has failed to find a direct association between fornix degeneration and hippocampal atrophy [16,[85], [86], [87]], Wallerian degeneration would not be enough to explain early changes in the fornix.

On the contrary, the retrogenesis model assumes primary WM changes through myelin breakdown and axonal damage that develops in a reverse pattern of myelinogenesis during brain development [17,83,84]. This process would first affect late-myelinating fibers during brain development (limbic system and the cortico-cortical association tracts) due to their thinner myelin sheaths and, more severely, those of small dimeter such as the fornix [17], [18], [19].

The fact that fornix degeneration appears at preclinical phases of AD disease, and that it has a strategic location within the memory circuitry, makes it a good candidate for an early AD biomarker [20]. Several groups have found that amnesic mild cognitive impairment (aMCI) patients that later progressed to AD have reduced FA and increased RD in the fornix, compared with healthy controls [16,88,89]. Moreover, in a longitudinal study by Nowrangi et al., an increasing MD in the fornix was observed in aMCI patients over time, proposing this parameter as a good indicator of clinical progression [90]. Notably, forniceal WM changes have also been reported as a biomarker of conversion from cognitively normal subjects to aMCI [85]. In a cross-sectional study, Zhuang et al. reported that early aMCI subjects (cognitively normal subjects that progressed to aMCI within the 2 years of the study) already showed impaired WM in the fornix when they were cognitively normal. Those microstructural changes were extended to the parahippocampal WM tract, cingulum and uncinate fasciculus in late aMCI patients. Oishi et al. and Fletcher et al. have also reported that WM changes in the fornix predict conversion from cognitively normal subjects to aMCI [72,91].

Whether microstructural WM changes in the fornix are the cause or consequence of the neurodegeneration occurring in the hippocampus, the main structural biomarker of neurodegeneration proposed by the National Institute on Aging-Alzheimer's Association [92], has been largely debated. However, forniceal changes have been detected in early aMCI patients in absence of hippocampal atrophy [85], which suggest that WM alterations in this tract are independent from neuronal damage in the hippocampus and may occur directly within the axons, supposedly, by some myelin pathology or WM inflammation [93,94]. In line with this hypothesis, a study performed in cognitively normal elderly subjects with hippocampal atrophy and decreased FA in the fornix reported that changes in fornix microstructure preceded hippocampal atrophy when a sequential relationship was evaluated [86]. Accordingly, other studies have also failed to find an association between WM changes in the fornix and atrophy of the medial temporal lobe (entorhinal cortex or hippocampus) in aMCI or early AD patients [16,87]. However, there is, indeed, an association between fornix degeneration and hippocampal atrophy when looking at the specific hippocampal area harboring the cell bodies of forniceal axons. In two studies by Wiss et al. and Lee et al., performed in aMCI and early AD patients, decreased FA in the fornix was associated exclusively with decreased volume in the subiculum and CA1, but not with other hippocampal subfields [70,95]. The highly restricted location of gray matter atrophy associated with fornix degeneration suggests that neuronal death in the subiculum or CA1 could be due to delayed apoptosis or retrograde degeneration similar to that described in axotomy [96], [97], [98].

The association between WM changes in the fornix and the main hallmark of AD (Aβ deposition in the brain) has been explored by some authors. Reduced FA in the fornix was correlated with Aβ deposition when assessed with positron emission tomography in both cognitively normal and MCI subjects [99,100]. Also, in a cognitively normal population, lower Aβ42/p-tau181 ratios in the cerebrospinal fluid, a highly specific biomarker of AD [101], corresponded with altered WM integrity in the fornix, which also was associated to a lower performance in cognitive tests [102]. In a group of healthy subjects carrying mutations for presenilin and apolipoprotein (at high risk of developing a familial form of AD), fornix integrity was already compromised in absence of hippocampal atrophy, suggesting that forniceal changes may precede and be independent of hippocampal atrophy also in the familial form of AD [103]. However, the physiological mechanisms underlying forniceal damage in these subjects may not be comparable to the ones in late-onset AD due to the unidentified effects that these mutations may have in fornix structure during brain development.

APOE ε4 allele carriers, the strongest genetic factor known to increase the risk of late-onset AD [104,105], have also shown microstructural WM changes in the fornix at pre-symptomatic phases of the disease [59,94]. In this case, the aberran deposition of cholesterol in oligodendrocytes and the reduced axonal myelination, suposedly caused by cholesterol homeostasis and transport dysregulation, could be a major factor of WM degeneration and loss of function [106].

All these studies support that WM changes in the fornix are present at a very early stage of the disease, and often precede the structural alterations occurring in the hippocampus, but it remains unclear what causes forniceal degeneration at such early stages. Chronic hypoperfusion, ischemic processes, neuroinflammation, demyelination and axonal loss are some putative factors proposed by DTI studies that can alter the microstructure of the WM tracts in AD [49,107,108]. Actually, WM degeneration (independent of gray matter lesions) has been confirmed by post-mortem studies [109], [110], [111]. Demyelination, astrogliosis, axonal and oligodendrocyte loss in the deep WM have been reported from the autopsies.

5. Risk factors of AD can affect fornix microstructure through cerebrovascular pathology and neuroinflammation

Brain network dynamics are modulated by daily life factors such as education, diet, and physical exercise [112]. Over time, all of these factors will also mediate the degenerative process. Several risk factors of late-onset AD are known to impair the WM microstructure by triggering cerebrovascular pathology and neuroinflammation. Here, we describe some of the risk factors of AD in which the fornix has been reportedly affected. The fornix could be especially vulnerable to these pathological events not only because it is a part of the late-myelinating fibers of small diameter [17], but also because of its marked metabolic demand in comparison with other WM fibers [113].

5.1. Aging

Aging is the primary risk factor of neurodegeneration and dementia. Most DTI-based studies agree on WM microstructure being altered in elderly people [21,22]. The vast majority of studies performed with DTI have reported changes in integrity and density in the fornix (reviewed by Douet and Chang, [74]). Those changes are thought to be a consequence of local fiber degeneration and less likely a secondary event following hippocampal degeneration [114]. Indeed, recent studies using NODDI and quantitative magnetization transfer (qMT, an image modality sensitive to microglia-mediated inflammation) have reported that aging was associated with apparent glia but not neurite density damage in the fornix and have also confirmed that fornix WM glia damage causes hippocampal gray matter damage during age-dependent limbic decline [115].

Impaired cerebrovascular hemodynamics and inflammation are some of the age-related factors that can contribute to WM damage. The increased pulse pressure waves penetrating the cerebral microcirculation as a result of reduced arterial myogenic responses, may contribute to WM damage, and it has been reported to precipitate cognitive deficits in the elderly [116], [117], [118]. Also, the so-called ‘inflammaging’, potentially caused by an age-triggered imbalance in cytokine homeostasis, can precipitate WM degeneration [119].

5.2. Cardiovascular risk factors

CVRFs are linked to the appearance of vascular dementia and AD [120,121]. Epidemiological studies from the last decade suggest reductions in the prevalence of common CVRFs (smoking, high cholesterol, high blood pressure), while increasing prevalence of obesity and namely type 2 diabetes [122], pointing to the latter as the current major risk factor for cardiovascular diseases.

Patients with type 2 diabetes, have a greater risk of suffering from vascular cognitive impairment and dementia and late-onset AD in the elderly [123], [124], [125], but the underlying mechanisms are rather unknown. Novel DTI studies on type 2 diabetes have pointed to WM changes as a possible cause of cognitive impairments in these patients [126], and have confirmed the fornix as one of the impaired structures [26], [27], [28].

Moreover, either in obese (otherwise healthy) or non-obese elder people, body mass index negatively correlated with WM integrity, namely in the fornix and posterior regions of the corpus callosum [23], [24], [25]. The relationship between body mass and WM integrity could be related to altered vascular/inflammatory patterns, particularly in posterior regions of the corpus callosum and the fornix [113]. According to Bettcher et al., the greater impact of vascular and inflammatory factors associated to obesity on these two WM regions could be related to their marked metabolic demands and higher susceptibility to inflammatory processes in comparison with other WM fibers. Using MRI indices sensitive to demyelination and neuroinflammation (macromolecular proton fraction and kf) from qMT, Metzler-Baddeley et al., [127] found that in obese patients, abdominal visceral and subcutaneous fat area fractions were associated to microstructural changes in the fornix, but not in other regions studied such as parahippocampal cingulum, uncinate fasciculus, corticospinal tract, and the hippocampus. No differences in neurites dispersion were found with NODDI. Other studies, however, have found lower neurite density in the fornix associated with higher body mass index in cognitively normal obese patients [128].

5.3. Heart failure

Populations with heart failure have lower cardiac output, and the reduced blood flow pumped by the heart seems to have a detrimental impact on cerebral circulation [129], which may be associated to cognitive decline [130]. Interestingly, several studies have shown that cardiac dysfunction, in particular diastolic dysfunction, correlates with the severity of WM changes and cognitive decline [131], [132], [133]. Cardiovascular dysfunction has been related to reduced cerebral blood pressure leading to endothelial dysfunction and a decrease in nitric oxide (NO) production. Chronic depletion of NO biosynthesis induces oxidative stress and leads to pericytes loss, BBB disruption and neuronal toxicity [134]. On the other hand, oxidative stress induces pro-inflammatory mechanisms that exacerbate microvascular disease, and thus, aggravating WM damage [135,136].

Kumar et al., found that the volumes of the mammillary bodies and the fornix were significantly reduced in patients with heart failure manifesting spatial and working memory deficits [29]. Those differences remained after controlling for age, gender and intracranial volume. This would confirm the vulnerability of the fornix to cerebrovascular alterations.

5.4. Traumatic brain injury

The most relevant consequences of TBI are diffuse axonal injury caused by mechanical forces (shear stress) and cerebrovascular dysfunction (microhemorrhages, focal ischemia and edema) [137,138]. Namely, vascular pathology is associated with prolonged inflammation, BBB disruption, progressive WM damage and long-term neurodegeneration and disability [139,140]. Independently of the extent and location of the impact, TBI-related chronic inflammation is particularly evident in WM of subcortical regions and specially in the fornix [31], which could be explained by its high vulnerability to microvascular pathology and inflammation that follows TBI [139,141]. WM inflammation and degeneration persist for many years after trauma and likely increases the risk of developing AD later in life [142,143]. The key role of WM inflammation in cognitive impairments after TBI has been widely studied in patients.

Adult TBI patients (∼40 years old), showed persistent microglia activation ([11C](R)PK11195 (PK) binding in positron emission tomography imaging) in the internal capsule, putamen and, especially, in WM surrounding thalamic nuclei (fornix). However, only microglia activation in the latter correlated with lower executive function performance [144]. Another study in chronic TBI patients (∼26 years old) observed decreased FA in main WM tracts such as corpus callosum, internal and external capsule, superior and inferior longitudinal fascicles, and the fornix [30].

Intriguingly, in adolescent mild TBI patients (∼15 years old), Yallampalli et al., found an unexpected increased FA in acute phases, compared to controls, which they attributed to cytotoxicity and inflammation preceding myelin degeneration at more chronic phases [31]. This increased FA was associated with decreased processing speed in the Automated Neuropsychological Assessment Metrics Battery.

These studies strongly support that cognitive deficits in TBI individuals are related to network dysfunction and disconnection and could facilitate the appearance of AD later on [145,146].

6. Cerebrovascular disease and chronic white matter inflammation as a potential fornix modifier

Among the molecular and physiological mechanisms proposed as initiators of retrogenesis, cerebrovascular disease and neuroinflammation could be especially relevant considering the well-known susceptibility of WM to these conditions [83].

Cerebrovascular pathology and chronic WM inflammation has been observed in animal models of different conditions known to increase the risk of dementia: global cerebral ischemia (mimicking heart failure), aging, obesity, hypercholesterolemia, type 2 diabetes, and diffuse axonal damage after TBI [147], [148], [149], [150], [151], [152], [153], [154], [155]. Arterial stiffens and intermittent/chronic hypoxia lead to remodeling of the microvasculature and inflammation in WM [7,156]. Microvasculature remodeling induces readjustments in tight junctions of endothelial cells favoring blood-brain barrier (BBB) leakages and extravasation of blood components such as fibrinogen, a blood coagulation protein that promotes microglia activation through binding the CD11b-CD18 (MAC-1) surface receptor (Fig. 2A) [157], [158], [159]. Although neuroinflammation is intended as a protective process, chronic inflammation can be more harmful than beneficial [160].

Fig. 2.

Fig 2

Schematic representation of a hypothetical model of fornix degeneration due to risk factors of Alzheimer's disease. A) Blood-brain barrier permeability induces inflammation of the white matter. The readjustment of endothelial tight junctions in response to a compromised blood microcirculation facilitates the extravasation of fibrinogen, capable of activating microglia. Reactive microglia can maintain and extend inflammation by releasing Gal-3 acting through TLR4. Reactive microglia phagocyte degenerated myeline and releases pro-NGF and TNFα that may impact oligodendrocytes viability and reduce retrograde axonal transport, thus, neuronal survival. B) Phagocytic phenotype in microglia is sustained by Gal-3 expression. Fibrinogen promotes microglia activation through binding the MAC-1 surface receptor. Gal-3 acts as a molecular switch that up-regulates and prolongs PI3K activity maintaining a phagocytic phenotype in microglia. Gal-3; galectin-3, TLR4; toll-like receptor 4, TNFα; tumor necrosis factor alpha; I3K; phosphatidylinositol 3-kinase; NGF, nerve growth factor; GTP, guanosine triphosphate; GDP, guanosine diphosphate; GEFs, guanine nucleotide exchange factors; GAPs, GTPase-activating proteins.

Interestingly, all the above-mentioned animal models of risk factors of AD have reported the chronic activation of a subset of microglia expressing Galectin-3 (Gal-3, formally known as MAC-2) in the WM. Increased Gal-3 positive microglia has been associated with cognitive deficits in some models, for example, in aged rhesus monkey or hypercholesterolemic and diabetic mice [149,154,155]. Moreover, the presence of microgliosis in the WM, and namely Gal-3 positive microglia, is associated with a deficient electrical impulse transition in WM fibers [161,162], which suggests a detrimental impact on WM function. However, the causation still must be investigated.

Gal-3 is a β-galactoside-binding lectin that, presumably, promotes myelin-phagocytosis in MAC-1-activated microglia [163]. Namely, it acts as a molecular switch that up-regulates and prolongs K-Ras-GTP-dependent phosphatidylinositol 3-kinase (PI3K) activity (Fig. 2B) [163]. Gal-3 also targets the cytoskeleton, regulating microglia phenotype from branched (non-phagocytic) to amoeboid and phagocytic [164,165]. Moreover, as confirmed in several murine models of neuroinflammation (global brain ischemia or lipopolysaccharide (LPS)-induced inflammation), Gal-3 released by microglia seems to act as an endogenous paracrine toll-like receptor 4 ligand, prolonging the inflammatory response in the brain by sustaining microglia activation [150]. Accordingly, depletion of Gal-3 exerted neuroprotective and anti-inflammatory effects in these models.

On the other hand, some groups have proposed that Gal-3 microglia activation follows oligodendrocyte or myelin abnormalities, and play a role in myelin sheath reparation by releasing nerve growth factor (NGF) and phagocytosing the degenerated myelin [148,166]. NGF is a neurotrophin implicated in cell survival/proliferation and angiogenesis. It also plays an important role in axonal regeneration by promoting differentiation of oligodendrocytes and facilitating migration and proliferation of oligodendrocyte precursor cells to sites of myelin damage. However, others have reported that microglia are instead actively implicated in oligodendroglial dysfunction and death by releasing the precursor form of NGF (proNGF) upon LPS-induced WM inflammation [167,168]. The lack of specificity of some anti-NGF antibodies for labeling the immature or mature form of the neurotrophin has been an important confounding factor in the literature over the years [169]. Therefore, whether Gal-3 microglia express proNGF and not NGF, which will have a detrimental effect on WM structure, remains elusive.

NGF has a high affinity for TrkA/p75NTR receptor, which mediates its trophic effects within the brain, while proNGF has a similar affinity for TrkA/p75NTR receptor and sortilin/p75NTR complex, the latter mediating the apoptotic pathway of the neurotrophin (e.g., oligodendrocyte death, acellular vessels, BBB disruption, neuronal death). Under pathological conditions, an imbalance in TrkA vs p75NTR receptor ratios increases the sortilin/p75NTR complex formation responsible for the proNGF switch from neurotrophic to apoptotic activity [170,171]. In this context, the overproduction of proNGF by reactive microglia would be fatal, especially within the fornix, which has shown an increased microglial activation capacity in response to stressors compared to other WM regions [172].

The p75NTR receptor is highly expressed by neurons and glial cells under pathological conditions such as mechanical damage, focal ischemia, stroke, diabetes and AD, which may promote the apoptotic path of proNGF [173,174]. In fact, it has been shown that proNGF released by activated microglia in spinal cord injury mediates oligodendrocyte cell death by binding p75NTR [167]. Hence, it would be interesting to understand whether the combination of an increased expression of proNGF by microglia and p75NTR receptor in target glial cell populations could explain some aspects of WM degeneration in risk factors of AD and if these mechanisms are also valid in the context of AD.

In addition to myelin degeneration and oligodendrocyte death, proNGF and the pro-inflammatory cytokine tumor necrosis factor α (TNFα) released by microglia, are suspected to impair retrograde axonal transport causing neuronal dysfunction and death over time (Fig. 2A) [175].

7. Concluding remarks

Changes in lifestyle, early detection of CVRFs in midlife populations, and therapeutic interventions targeting the brain vasculature, therefore ensuring healthy hemodynamics, may constitute effective avenues for the clinical management of populations at high risk of suffering from late-onset AD with a vascular component.

Understanding what triggers WM changes, and the link with vascular pathology, will shed light on the relationship between the cerebrovascular dysfunction seen in many risk factors of AD and the neurodegeneration finally leading to cognitive decline. Namely, early detection of fornix degeneration in patients with CVRFs or TBI could help prevent the development of cognitive deficits or dementia later in life.

On the other side, understanding what causes WM pathology in the fornix, and the cascade of events leading to WM dysfunction, could help the optimization of techniques such as DBS-f for the treatment of cognitive decline, as well as other pharmacological or nonpharmacological approaches aiming to halt WM degeneration. For this reason, more research is necessary to reveal the specific cellular and molecular mechanisms causing WM damage in risk factors of AD.

CRediT authorship contribution statement

María Lacalle-Aurioles: Writing – review & editing, Conceptualization. Yasser Iturria-Medina: Writing – review & editing.

Declaration of Competing Interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Acknowledgments

The authors would like to thank Dr Lianne Trigiani and Miss Anita Kriz for editing the manuscript and Dr Maria Zamfir for the illustration in figure 2. The authors did not receive financial support for the preparation of this manuscript.

References

  • 1.Gustafson D.R., Clare Morris M., Scarmeas N., et al. New perspectives on Alzheimer's disease and nutrition. J. Alzheimers Dis. 2015;46:1111–1127. doi: 10.3233/JAD-150084. [DOI] [PubMed] [Google Scholar]
  • 2.Dhana K., Evans D.A., Rajan K.B., et al. Healthy lifestyle and the risk of Alzheimer dementia. Neurology. 2020;95:e374–e383. doi: 10.1212/WNL.0000000000009816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rosendorff C., Beeri M.S., Silverman J.M. Cardiovascular risk factors for Alzheimer's disease. Am. J. Geriatr. Cardiol. 2007;16:143–149. doi: 10.1111/j.1076-7460.2007.06696.x. [DOI] [PubMed] [Google Scholar]
  • 4.Van Den Heuvel C., Thornton E., Vink R. Traumatic brain injury and Alzheimer's disease: a review. Prog. Brain Res. 2007;161:303–316. doi: 10.1016/S0079-6123(06)61021-2. [DOI] [PubMed] [Google Scholar]
  • 5.Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844–866. doi: 10.1016/j.neuron.2013.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rajani R.M., Quick S., Ruigrok S.R., et al. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Sci. Transl. Med. 2018;10:eaam9507. doi: 10.1126/scitranslmed.aam9507. [DOI] [PubMed] [Google Scholar]
  • 7.Hase Y., Ding R., Harrison G., et al. White matter capillaries in vascular and neurodegenerative dementias. Acta Neuropathol. Commun. 2019;7:16. doi: 10.1186/s40478-019-0666-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Delbeuck X., Van Der Linden M., Collette F. Alzheimer's disease as a disconnection syndrome? Neuropsychol. Rev. 2003;13:79–92. doi: 10.1023/a:1023832305702. [DOI] [PubMed] [Google Scholar]
  • 9.Brier M.R., Thomas J.B., Ances B.M. Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect. 2014;4:299–311. doi: 10.1089/brain.2014.0236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fellgiebel A., Schermuly I., Gerhard A., et al. Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease. Neuropsychologia. 2008;46:1698–1706. doi: 10.1016/j.neuropsychologia.2007.12.010. [DOI] [PubMed] [Google Scholar]
  • 11.Mielke M.M., Kozauer Na, Chan K.C.G., et al. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage. 2009;46:47–55. doi: 10.1016/j.neuroimage.2009.01.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhang Y., Schuff N., Jahng G.-.H., et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology. 2007;68:13–19. doi: 10.1212/01.wnl.0000250326.77323.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Teipel S.J., Stahl R., Dietrich O., et al. Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage. 2007;34:985–995. doi: 10.1016/j.neuroimage.2006.07.047. [DOI] [PubMed] [Google Scholar]
  • 14.Rose S.E., Mc Mahon K.L., Janke A.L., et al. Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry. 2006;77:1122–1128. doi: 10.1136/jnnp.2005.074336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rose S.E., Chen F., Chalk J.B., et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry. 2000;69:528–530. doi: 10.1136/jnnp.69.4.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lacalle-Aurioles M., Javier Navas-Sánchez F., Alemán-Gómez Y., et al. The disconnection hypothesis in Alzheimer's disease studied through multimodal magnetic resonance imaging: structural, perfusion, and diffusion tensor imaging. J. Alzheimers Dis. 2016;50:1051–1064. doi: 10.3233/JAD-150288. [DOI] [PubMed] [Google Scholar]
  • 17.Stricker N.H., Schweinsburg B.C., Delano-Wood L., et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage. 2009;45:10–16. doi: 10.1016/j.neuroimage.2008.11.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kantarci K. Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's disease. Front. Aging Neurosci. 2014;6:316. doi: 10.3389/fnagi.2014.00316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Oishi K., Lyketsos C.G. Alzheimer's disease and the fornix. Front. Aging Neurosci. 2014;6:241. doi: 10.3389/fnagi.2014.00241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nowrangi M.A., Rosenberg P.B. The fornix in mild cognitive impairment and Alzheimer's disease. Front. Aging Neurosci. 2015;7(1) doi: 10.3389/fnagi.2015.00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Peters A., Sethares C., Moss M.B. How the primate fornix is affected by age. J. Comp. Neurol. 2010;518:3962–3980. doi: 10.1002/cne.22434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gunbey H.P., Ercan K., Fındıkoglu A.S., et al. The limbic degradation of aging brain: a quantitative analysis with diffusion tensor imaging. Sci. World J. 2014;2014:1–7. doi: 10.1155/2014/196513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Marks B., Katz L., Styner M., Smith J. Aerobic fitness and obesity: relationship to cerebral white matter integrity in the brain of active and sedentary older adults. Br. J. Sports Med. 2011;45:1208–1215. doi: 10.1136/bjsm.2009.068114. [DOI] [PubMed] [Google Scholar]
  • 24.Stanek K.M., Grieve S.M., Brickman A.M., et al. Obesity is associated with reduced white matter integrity in otherwise healthy adults. Obesity. 2011;19:500–504. doi: 10.1038/oby.2010.312. [DOI] [PubMed] [Google Scholar]
  • 25.Xu J., Li Y., Lin H., et al. Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: a diffusion tensor imaging study. Hum. Brain Mapp. 2013;34:1044–1052. doi: 10.1002/hbm.21491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tan X., Fang P., An J., et al. Micro-structural white matter abnormalities in type 2 diabetic patients: a DTI study using TBSS analysis. Neuroradiology. 2016;58:1209–1216. doi: 10.1007/s00234-016-1752-4. [DOI] [PubMed] [Google Scholar]
  • 27.Nouwen A., Chambers A., Chechlacz M., et al. Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes. NeuroImage Clin. 2017;16:43–51. doi: 10.1016/j.nicl.2017.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhuo Y., Fang F., Lu L., et al. White matter impairment in type 2 diabetes mellitus with and without microvascular disease. NeuroImage Clin. 2019;24 doi: 10.1016/j.nicl.2019.101945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kumar R., Woo M.A., Birrer B.V.X., et al. Mammillary bodies and fornix fibers are injured in heart failure. Neurobiol. Dis. 2009;33:236–242. doi: 10.1016/j.nbd.2008.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Xu J., Rasmussen I.A., Lagopoulos J., Håberg A. Diffuse axonal injury in severe traumatic brain injury visualized using high-resolution diffusion tensor imaging. J. Neurotrauma. 2007;24:753–765. doi: 10.1089/neu.2006.0208. [DOI] [PubMed] [Google Scholar]
  • 31.Yallampalli R., Wilde E.A., Bigler E.D., et al. Acute white matter differences in the fornix following mild traumatic brain injury using diffusion tensor imaging. J. Neuroimaging. 2013;23:224–227. doi: 10.1111/j.1552-6569.2010.00537.x. [DOI] [PubMed] [Google Scholar]
  • 32.Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256:184–185. doi: 10.1126/science.1566067. [DOI] [PubMed] [Google Scholar]
  • 33.Mc Khann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984;34:939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  • 34.Larson E.B., Yaffe K., Langa K.M. New insights into the dementia epidemic. N. Engl. J. Med. 2013;369:2275–2277. doi: 10.1056/NEJMp1311405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nichols E., Szoeke C.E.I., Vollset S.E., et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:88–106. doi: 10.1016/S1474-4422(18)30403-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.De La Torre J.C., Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res. 1993;15:146–153. doi: 10.1080/01616412.1993.11740127. [DOI] [PubMed] [Google Scholar]
  • 37.Wiesmann M., Kiliaan A.J., Claassen J.A.H.R. Vascular aspects of cognitive impairment and dementia. J. Cereb. Blood Flow Metab. 2013;33:1696–1706. doi: 10.1038/jcbfm.2013.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dickstein D.L., Walsh J., Brautigam H., et al. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt. Sinai J. Med. 2010;77:82–102. doi: 10.1002/msj.20155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Toledo J.B., Arnold S.E., Raible K., et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's coordinating centre. Brain. 2013;136:2697–2706. doi: 10.1093/brain/awt188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Iturria-Medina Y., Sotero R.C., Toussaint P.J., et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat. Commun. 2016;7:11934. doi: 10.1038/ncomms11934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Iturria-Medina Y., Hachinski V., Evans A.C. The vascular facet of late-onset Alzheimer's disease. Curr. Opin. Neurol. 2017;30:623–629. doi: 10.1097/WCO.0000000000000497. [DOI] [PubMed] [Google Scholar]
  • 42.Klohs J. An integrated view on vascular dysfunction in Alzheimer's disease. Neurodegener Dis. 2020:1–19. doi: 10.1159/000505625. [DOI] [PubMed] [Google Scholar]
  • 43.Iturria-Medina Y., Carbonell F.M., Sotero R.C., et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: application to Alzheimer's disease. Neuroimage. 2017;152:60–77. doi: 10.1016/j.neuroimage.2017.02.058. [DOI] [PubMed] [Google Scholar]
  • 44.Iturria-Medina Y., Hachinski V., Evans A.C. (2017) The vascular facet of late-onset Alzheimer's disease. Curr. Opin. Neurol. 30:623–629. 10.1097/WCO.0000000000000497. [DOI] [PubMed]
  • 45.Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4:316–329. doi: 10.1016/j.nurt.2007.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Aung W.Y., Mar S., Benzinger T.L. Diffusion tensor MRI as a biomarker in axonal and myelin damage. Imaging Med. 2013;5:427–440. doi: 10.2217/iim.13.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B. 1996;111:209–219. doi: 10.1006/jmrb.1996.0086. [DOI] [PubMed] [Google Scholar]
  • 48.Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002;15:435–455. doi: 10.1002/nbm.782. [DOI] [PubMed] [Google Scholar]
  • 49.Mori S., Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron. 2006;51:527–539. doi: 10.1016/j.neuron.2006.08.012. [DOI] [PubMed] [Google Scholar]
  • 50.Madden D.J., Bennett I.J., Burzynska A., et al. Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. Biochim. Biophys. Acta. 2012;1822:386–400. doi: 10.1016/j.bbadis.2011.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Stebbins G.T., Murphy C.M. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav. Neurol. 2009;21:39–49. doi: 10.3233/BEN-2009-0234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wang Z., Wang J., Zhang H., et al. Interhemispheric functional and structural disconnection in Alzheimer's disease: a combined resting-state fMRI and DTI study. PLoS ONE. 2015;10 doi: 10.1371/journal.pone.0126310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Bozzali M., Padovani A., Caltagirone C., Borroni B. Regional grey matter loss and brain disconnection across Alzheimer disease evolution. Curr. Med. Chem. 2011;18:2452–2458. doi: 10.2174/092986711795843263. [DOI] [PubMed] [Google Scholar]
  • 54.Drzezga A., Becker J.A., Van Dijk K.R.A., et al. Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain. 2011;134:1635–1646. doi: 10.1093/brain/awr066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Dai Z., Lin Q., Li T., et al. Disrupted structural and functional brain networks in Alzheimer's disease. Neurobiol. Aging. 2019;75:71–82. doi: 10.1016/j.neurobiolaging.2018.11.005. [DOI] [PubMed] [Google Scholar]
  • 56.Delbeuck X., Collette F., Van Der Linden M. Is Alzheimer's disease a disconnection syndrome? evidence from a crossmodal audio-visual illusory experiment. Neuropsychologia. 2007;45:3315–3323. doi: 10.1016/j.neuropsychologia.2007.05.001. [DOI] [PubMed] [Google Scholar]
  • 57.Cremers L.G.M., Wolters F.J., de Groot M., et al. Structural disconnectivity and the risk of dementia in the general population. Neurology. 2020;95:e1528–e1537. doi: 10.1212/WNL.0000000000010231. [DOI] [PubMed] [Google Scholar]
  • 58.Sachdev P.S., Zhuang L., Braidy N., Wen W. Is Alzheimer's a disease of the white matter? Curr. Opin. Psychiatry. 2013;26:244–251. doi: 10.1097/YCO.0b013e32835ed6e8. [DOI] [PubMed] [Google Scholar]
  • 59.Gold B.T., Johnson N.F., Powell D.K., Smith C.D. White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. Biochim. Biophys. Acta Mol. Basis Dis. 2012;1822:416–422. doi: 10.1016/j.bbadis.2011.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Geschwind N. Disconnexion syndromes in animals and man. Brain. 1965;88:237. doi: 10.1093/brain/88.2.237. [DOI] [PubMed] [Google Scholar]
  • 61.Chen S., Kang Z., Hu X., et al. Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions. J. Zhejiang Univ. Sci. B. 2007;8:242–247. doi: 10.1631/jzus.2007.B0242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Fu X., Shrestha S., Sun M., et al. Microstructural white matter alterations in mild cognitive impairment and alzheimer's disease : study based on neurite orientation dispersion and density imaging (NODDI) Clin. Neuroradiol. 2020;30:569–579. doi: 10.1007/s00062-019-00805-0. [DOI] [PubMed] [Google Scholar]
  • 63.Kringelbach M.L., Jenkinson N., Owen S.L.F., Aziz T.Z. Translational principles of deep brain stimulation. Nat. Rev. Neurosci. 2007:623–635. doi: 10.1038/nrn2196. [DOI] [PubMed] [Google Scholar]
  • 64.Laxton A.W., Tang-Wai D.F., Mc Andrews M.P., et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann. Neurol. 2010;68:521–534. doi: 10.1002/ana.22089. [DOI] [PubMed] [Google Scholar]
  • 65.Lozano A.M., Fosdick L., Chakravarty M.M., et al. A phase II study of fornix deep brain stimulation in mild Alzheimer's disease. J. Alzheimers Dis. 2016;54:777–787. doi: 10.3233/JAD-160017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Leoutsakos J.M.S., Yan H., Anderson W.S., et al. Deep brain stimulation targeting the fornix for mild Alzheimer dementia (the advance trial): a two year follow-up including results of delayed activation. J. Alzheimers Dis. 2018;64:597–606. doi: 10.3233/JAD-180121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Nieuwenhuys R., Voogd J., Van Huijzen C. 4th ed. Springer Science & Business Media; 2007. The Human Central Nervous system: a Synopsis and Atlas. [Google Scholar]
  • 68.Huh C.Y.L., Danik M., Manseau F., et al. Chronic exposure to nerve growth factor increases acetylcholine and glutamate release from cholinergic neurons of the rat medial septum and diagonal band of broca via mechanisms mediated by p75NTR. J. Neurosci. 2008;28:1404–1409. doi: 10.1523/JNEUROSCI.4851-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Senova S., Fomenko A., Gondard E., Lozano A.M. Anatomy and function of the fornix in the context of its potential as a therapeutic target. J. Neurol. Neurosurg. Psychiatry. 2020;91:547–559. doi: 10.1136/jnnp-2019-322375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Lee D.Y., Fletcher E., Carmichael O.T., et al. Sub-regional hippocampal injury is associated with fornix degeneration in Alzheimer's disease. Front. Aging Neurosci. 2012;4(1) doi: 10.3389/fnagi.2012.00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Gold C.A., Budson A.E. Memory loss in Alzheimer's disease: implications for development of therapeutics. Expert Rev. Neurother. 2008;8:1879–1891. doi: 10.1586/14737175.8.12.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Fletcher E., Raman M., Huebner P., et al. Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals. JAMA Neurol. 2013;70:1389–1395. doi: 10.1001/jamaneurol.2013.3263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav. Brain Sci. 1999;22:425–444. [PubMed] [Google Scholar]
  • 74.Douet V., Chang L. Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders. Front. Aging Neurosci. 2015;6:343. doi: 10.3389/fnagi.2014.00343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.McMackin D., Cockburn J., Anslow P., Gaffan D. Correlation of fornix damage with memory impairment in six cases of colloid cyst removal. Acta Neurochir. 1995;135:12–18. doi: 10.1007/BF02307408. (Wien) [DOI] [PubMed] [Google Scholar]
  • 76.Adamovich B.L., Gualberto G., Roberts T., et al. teaching neuroimages: amnesia due to fornix infarction. Neurology. 2009;73:e86. doi: 10.1212/WNL.0b013e3181bd80af. [DOI] [PubMed] [Google Scholar]
  • 77.Carlesimo G.A. Memory disorders in patients with cerebral tumors. J. Neurooncol. 2012;108:253–256. doi: 10.1007/s11060-012-0825-4. [DOI] [PubMed] [Google Scholar]
  • 78.Gangadharan G., Shin J., Kim S.W., et al. Medial septal GABAergic projection neurons promote object exploration behavior and type 2 theta rhythm. Proc. Natl. Acad. Sci. U S A. 2016;113:6550–6555. doi: 10.1073/pnas.1605019113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Whittemore S.R., Seiger A. The expression, localization and functional significance of beta-nerve growth factor in the central nervous system. Brain Res. 1987;434:439–464. doi: 10.1016/0165-0173(87)90008-7. [DOI] [PubMed] [Google Scholar]
  • 80.Debeir T., Saragovi H.U., Cuello A.C. A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc. Natl. Acad. Sci. U S A. 1999;96:4067–4072. doi: 10.1073/PNAS.96.7.4067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Rudebeck S.R., Scholz J., Millington R., et al. Fornix microstructure correlates with recollection but not familiarity memory. J. Neurosci. 2009;29:14987–14992. doi: 10.1523/JNEUROSCI.4707-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Nestor P.G., Kubicki M., Kuroki N., et al. Episodic memory and neuroimaging of hippocampus and fornix in chronic schizophrenia. Psychiatry Res. Neuroimaging. 2007;155:21–28. doi: 10.1016/j.pscychresns.2006.12.020. [DOI] [PubMed] [Google Scholar]
  • 83.Reisberg B., Franssen E.H., Souren L.E.M., et al. Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import. Am. J. Alzheimers Dis. Other Dement. 2002;17:202–212. doi: 10.1177/153331750201700411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Alves G.S., Oertel Knöchel V., Knöchel C., et al. Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity. Biomed. Res. Int. 2015 doi: 10.1155/2015/291658. 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Zhuang L., Sachdev P.S., Trollor J.N., et al. Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One. 2013;8 doi: 10.1371/journal.pone.0058887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Pelletier A., Periot O., Dilharreguy B., et al. Structural hippocampal network alterations during healthy aging: a multi-modal MRI study. Front. Aging. Neurosci. 2013;5(84) doi: 10.3389/fnagi.2013.00084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Agosta F., Pievani M., Sala S., et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology. 2011;258:853–863. doi: 10.1148/radiol.10101284. [DOI] [PubMed] [Google Scholar]
  • 88.Zhuang L., Wen W., Trollor J.N., et al. Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J. Alzheimers Dis. 2012;29:629–639. doi: 10.3233/JAD-2012-111766. [DOI] [PubMed] [Google Scholar]
  • 89.Van Bruggen T., Stieltjes B., Thomann P.A., et al. Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion? Psychiatry Res. Neuroimaging. 2012;203:184–193. doi: 10.1016/j.pscychresns.2011.12.003. [DOI] [PubMed] [Google Scholar]
  • 90.Nowrangi M.A., Lyketsos C.G., Leoutsakos J.M.S., et al. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement. 2013;9:519–528. doi: 10.1016/j.jalz.2012.05.2186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Oishi K., Mielke M.M., Albert M., et al. The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. J. Neuroimaging. 2012;22:365–374. doi: 10.1111/j.1552-6569.2011.00633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Jack C.R., Bennett D.A., Blennow K., et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535–562. doi: 10.1016/j.jalz.2018.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Salat D.H., Tuch D.S., Van Der Kouwe A.J.W., et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging. 2010;31:244–256. doi: 10.1016/j.neurobiolaging.2008.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Gold B.T., Powell D.K., Andersen A.H., Smith C.D. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. Neuroimage. 2010;52:1487–1494. doi: 10.1016/j.neuroimage.2010.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Wisse L.E.M., Reijmer Y.D., Ter Telgte A., et al. hippocampal disconnection in early Alzheimer's disease: a 7 tesla MRI study. J. Alzheimers Dis. 2015;45:1247–1256. doi: 10.3233/JAD-142994. [DOI] [PubMed] [Google Scholar]
  • 96.Berkelaar M., Clarke D.B., Wang Y.C., et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 1994;14:4368–4374. doi: 10.1523/JNEUROSCI.14-07-04368.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Villegas-Pérez M.P., Vidal-Sanz M., Bray G.M., Aguayo A.J. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J. Neurosci. 1988;8:265–280. doi: 10.1523/JNEUROSCI.08-01-00265.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Martin L.J., Price A.C., Mc Clendon K.B., et al. Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. J. Neurochem. 2003;85:234–247. doi: 10.1046/j.1471-4159.2003.01659.x. [DOI] [PubMed] [Google Scholar]
  • 99.Chao L.L., Decarli C., Kriger S., et al. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One. 2013;8:e65175. doi: 10.1371/journal.pone.0065175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Racine A.M., Adluru N., Alexander A.L., et al. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: a multimodal imaging investigation. NeuroImage Clin. 2014;4:604–614. doi: 10.1016/j.nicl.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Blasko I., Lederer W., Oberbauer H., et al. Measurement of thirteen biological markers in CSF of patients with Alzheimer?s disease and other dementias. Dement. Geriatr. Cogn. Disord. 2005;21:9–15. doi: 10.1159/000089137. [DOI] [PubMed] [Google Scholar]
  • 102.Gold B.T., Zhu Z., Brown C.A., et al. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Neurobiol. Aging. 2014;35:2263–2271. doi: 10.1016/j.neurobiolaging.2014.04.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Ringman J.M., O'Neill J., Geschwind D., et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain. 2007;130:1767–1776. doi: 10.1093/brain/awm102. [DOI] [PubMed] [Google Scholar]
  • 104.Westlye E.T., Hodneland E., Haász J., et al. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe. Neuroimage. 2012;63:507–516. doi: 10.1016/j.neuroimage.2012.06.072. [DOI] [PubMed] [Google Scholar]
  • 105.Montagne A., Nation D.A., Sagare A.P., et al. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71–76. doi: 10.1038/s41586-020-2247-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Blanchard J.W., Akay L.A., Davila-Velderrain J., et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611:769–779. doi: 10.1038/s41586-022-05439-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Xekardaki A., Giannakopoulos P., Haller S. White matter changes in bipolar disorder, Alzheimer disease, and mild cognitive impairment: new insights from DTI. J. Aging Res. 2011 doi: 10.4061/2011/286564. 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Zarei M., Damoiseaux J.S., Morgese C., et al. Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke. 2009;40:773–779. doi: 10.1161/STROKEAHA.108.530832. [DOI] [PubMed] [Google Scholar]
  • 109.Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 1986;19:253–262. doi: 10.1002/ana.410190306. [DOI] [PubMed] [Google Scholar]
  • 110.Englund E., Brun A. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology. 1990;16:433–439. doi: 10.1111/j.1365-2559.1990.tb01542.x. [DOI] [PubMed] [Google Scholar]
  • 111.Sjöbeck M., Haglund M., Englund E. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease–a neuropathological study. Int. J. Geriatr. Psychiatry. 2005;20:919–926. doi: 10.1002/gps.1384. [DOI] [PubMed] [Google Scholar]
  • 112.Chiang M.C., McMahon K.L., De Zubicaray G.I., et al. Genetics of white matter development: a DTI study of 705 twins and their siblings aged 12 to 29. Neuroimage. 2011;54:2308–2317. doi: 10.1016/j.neuroimage.2010.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Bettcher B.M., Walsh C.M., Watson C., et al. Body mass and white matter integrity: the influence of vascular and inflammatory markers. PLoS One. 2013;8:e77741. doi: 10.1371/journal.pone.0077741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Hof P.R., Morrison J.H. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci. 2004;27:607–613. doi: 10.1016/j.tins.2004.07.013. [DOI] [PubMed] [Google Scholar]
  • 115.Metzler-Baddeley C., Mole J.P., Sims R., et al. Fornix white matter glia damage causes hippocampal gray matter damage during age-dependent limbic decline. Sci. Rep. 2019;9:1060. doi: 10.1038/s41598-018-37658-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Purkayastha S., Fadar O., Mehregan A., et al. Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J. Cereb. Blood Flow Metab. 2013 doi: 10.1038/jcbfm.2013.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Tarumi T., Khan M.A., Liu J., et al. Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility. J. Cereb. Blood Flow Metab. 2014;34:971–978. doi: 10.1038/jcbfm.2014.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Waldstein S.R., Rice S.C., Thayer J.F., et al. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore longitudinal study of aging. Hypertension. 2008;51:99–104. doi: 10.1161/HYPERTENSIONAHA.107.093674. [DOI] [PubMed] [Google Scholar]
  • 119.Rea I.M., Gibson D.S., Mc Gilligan V., et al. Age and Age-Related Diseases: role of Inflammation Triggers and Cytokines. Front. Immunol. 2018;9:586. doi: 10.3389/fimmu.2018.00586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.De La Torre J.C. Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res. Rev. 2010;9:218–225. doi: 10.1016/j.arr.2010.04.002. [DOI] [PubMed] [Google Scholar]
  • 121.Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2014;131:e29–322. doi: 10.1161/CIR.0000000000000152. [DOI] [PubMed] [Google Scholar]
  • 122.Capewell S., Hayes D.K., Ford E.S., et al. Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. Am. J. Epidemiol. 2009;170:229–236. doi: 10.1093/aje/kwp150. [DOI] [PubMed] [Google Scholar]
  • 123.Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes–systematic overview of prospective observational studies. Diabetologia. 2005;48:2460–2469. doi: 10.1007/s00125-005-0023-4. [DOI] [PubMed] [Google Scholar]
  • 124.Crane P.K., Walker R., Hubbard R.A., et al. Glucose levels and risk of dementia. N. Engl. J. Med. 2013;369:540–548. doi: 10.1056/NEJMoa1215740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. doi: 10.1001/jama.289.1.76. [DOI] [PubMed] [Google Scholar]
  • 126.Zhang J., Wang Y., Wang J., et al. White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients. Diabetes. 2014;63:3596–3605. doi: 10.2337/db14-0342. [DOI] [PubMed] [Google Scholar]
  • 127.Metzler-Baddeley C., Mole J.P., Leonaviciute E., et al. Sex-specific effects of central adiposity and inflammatory markers on limbic microstructure. Neuroimage. 2019;189:793–803. doi: 10.1016/j.neuroimage.2019.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Noughani H.M., Ennis G.E., Vogt N.M., et al. Increased adiposity is related to reduced neurite complexity in the hippocampus, fornix, and uncinate fasciculus of cognitively unimpaired adults. Alzheimers Dement. 2021;17 doi: 10.1002/alz.057606. [DOI] [Google Scholar]
  • 129.Jefferson A.L., Tate D.F., Poppas A., et al. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J. Am. Geriatr. Soc. 2007;55:1044–1048. doi: 10.1111/j.1532-5415.2007.01226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Singh-Manoux A., Sabia S., Lajnef M., et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur. Heart J. 2008;29:2100–2107. doi: 10.1093/eurheartj/ehn298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Oh J.E., Shin J.W., Sohn E.H., et al. Effect of cardiac function on cognition and brain structural changes in dementia. J. Clin. Neurol. 2012;8:123–129. doi: 10.3988/jcn.2012.8.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Zuccalà G., Cattel C., Manes-Gravina E., et al. Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J. Neurol. Neurosurg. Psychiatry. 1997;63:509–512. doi: 10.1136/jnnp.63.4.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Suwa M., Ito T. Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases. Int. J. Cardiol. 2009;136:351–354. doi: 10.1016/j.ijcard.2008.04.099. [DOI] [PubMed] [Google Scholar]
  • 134.Thosar S.S., Johnson B.D., Johnston J.D., Wallace J.P. Sitting and endothelial dysfunction: the role of shear stress. Med. Sci. Monit. 2012;18:RA173–RA180. doi: 10.12659/msm.883589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Ergul A., Abdelsaid M., Fouda A.Y., Fagan S.C. Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J. Cereb. Blood Flow Metab. 2014;34:553–563. doi: 10.1038/jcbfm.2014.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Novak V., Last D., Alsop D.C., et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care. 2006;29:1529–1534. doi: 10.2337/dc06-0261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Armstrong R.C., Mierzwa A.J., Marion C.M., Sullivan G.M. White matter involvement after TBI: clues to axon and myelin repair capacity. Exp. Neurol. 2016;275:328–333. doi: 10.1016/j.expneurol.2015.02.011. [DOI] [PubMed] [Google Scholar]
  • 138.Logsdon A.F., Lucke-Wold B.P., Turner R.C., et al. Role of microvascular disruption in brain damage from traumatic brain injury. Compr. Physiol. 2015;5:1147–1160. doi: 10.1002/cphy.c140057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Glushakova O.Y., Johnson D., Hayes R.L. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J. Neurotrauma. 2014;31:1180–1193. doi: 10.1089/neu.2013.3080. [DOI] [PubMed] [Google Scholar]
  • 140.Sandsmark D.K., Bashir A., Wellington C.L., Diaz-Arrastia R. Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron. 2019;103:367–379. doi: 10.1016/j.neuron.2019.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.McKee A.C., Daneshvar D.H., Alvarez V.E., Stein T.D. The neuropathology of sport. Acta Neuropathol. 2014;127:29–51. doi: 10.1007/s00401-013-1230-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Johnson V.E., Stewart J.E., Begbie F.D., et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136:28–42. doi: 10.1093/brain/aws322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Donat C.K., Scott G., Gentleman S.M., Sastre M. Microglial activation in traumatic brain injury. Front. Aging Neurosci. 2017;9:208. doi: 10.3389/fnagi.2017.00208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Ramlackhansingh A.F., Brooks D.J., Greenwood R.J., et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol. 2011;70:374–383. doi: 10.1002/ana.22455. [DOI] [PubMed] [Google Scholar]
  • 145.Fagerholm E.D., Hellyer P.J., Scott G., et al. Disconnection of network hubs and cognitive impairment after traumatic brain injury. Brain. 2015;138:1696–1709. doi: 10.1093/brain/awv075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Sharp D.J., Scott G., Leech R. Network dysfunction after traumatic brain injury. Nat. Rev. Neurol. 2014;10:156–166. doi: 10.1038/nrneurol.2014.15. [DOI] [PubMed] [Google Scholar]
  • 147.Ekmark-Lewén S., Flygt J., Kiwanuka O., et al. Traumatic axonal injury in the mouse is accompanied by a dynamic inflammatory response, astroglial reactivity and complex behavioral changes. J. Neuroinflammation. 2013;10:44. doi: 10.1186/1742-2094-10-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Venkatesan C., Chrzaszcz M., Choi N., Wainwright M.S. Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J. Neuroinflammation. 2010;27:32. doi: 10.1186/1742-2094-7-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Shobin E., Bowley M.P., Estrada L.I., et al. Microglia activation and phagocytosis : relationship with aging and cognitive impairment in the rhesus monkey. Geroscience. 2017;39:199–220. doi: 10.1007/s11357-017-9965-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Burguillos M.A., Svensson M., Schulte T., et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015;10:1626–1638. doi: 10.1016/j.celrep.2015.02.012. [DOI] [PubMed] [Google Scholar]
  • 151.Qin S., Sun D., Mu J., et al. Purple sweet potato color improves hippocampal insulin resistance via down-regulating SOCS3 and galectin-3 in high-fat diet mice. Behav. Brain Res. 2019;359:370–377. doi: 10.1016/J.BBR.2018.11.025. [DOI] [PubMed] [Google Scholar]
  • 152.Yip P.K., Carrillo-Jimenez A., King P., et al. Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Sci. Rep. 2017;7:41689. doi: 10.1038/srep41689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Walther M., Kuklinski S., Pesheva P., et al. Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy. J. Neurosci. Res. 2000;61:430–435. doi: 10.1002/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 154.Tong X.K., Trigiani L.J., Hamel E. High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: benefits of simvastatin. Cell Death Dis. 2019;10:89. doi: 10.1038/s41419-018-1199-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Lacalle-Aurioles M., Royea J., Trigiani L., et al. White matter inflammation as a biomarker of cognitive impairment induced by mild diabetes in a mouse model of cerebrovascular disease. J. Cereb. Blood Flow Metab. 2017;37:403–404. [Google Scholar]
  • 156.Rosenberg G.A. Extracellular matrix inflammation in vascular cognitive impairment and dementia. Clin. Sci. 2017;131:425–437. doi: 10.1042/CS20160604. [DOI] [PubMed] [Google Scholar]
  • 157.Merlini M., Rafalski V.A., Rios Coronado P.E., et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model. Neuron. 2019;101:1099–1108. doi: 10.1016/j.neuron.2019.01.014. e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Davalos D., Kyu Ryu J., Merlini M., et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 2012;3:1227. doi: 10.1038/ncomms2230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Ryu J.K., McLarnon J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell Mol. Med. 2009;13:2911–2925. doi: 10.1111/j.1582-4934.2008.00434.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of Microglia. Physiol. Rev. 2011;91:461–553. doi: 10.1152/physrev.00011.2010. [DOI] [PubMed] [Google Scholar]
  • 161.Kitamura A., Manso Y., Duncombe J., et al. Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion. Sci. Rep. 2017;7:4299. doi: 10.1038/s41598-017-04082-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Trigiani L.J., Lacalle-Aurioles M., Bourourou M., et al. Benefits of physical exercise on cognition and glial white matter pathology in a mouse model of vascular cognitive impairment and dementia. Glia. 2020;68:1925–1940. doi: 10.1002/glia.23815. [DOI] [PubMed] [Google Scholar]
  • 163.Rotshenker S. The role of galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J. Mol. Neurosci. 2009;39:99–103. doi: 10.1007/s12031-009-9186-7. [DOI] [PubMed] [Google Scholar]
  • 164.Rahimian R., Béland L.C, Kriz J. Galectin-3: mediator of microglia responses in injured brain. Drug Discov. Today. 2018;23:375–381. doi: 10.1016/j.drudis.2017.11.004. [DOI] [PubMed] [Google Scholar]
  • 165.Reichert F., Rotshenker S. Galectin-3 (MAC-2) controls microglia phenotype whether amoeboid and phagocytic or branched and non-phagocytic by regulating the cytoskeleton. Front. Cell Neurosci. 2019;13:90. doi: 10.3389/fncel.2019.00090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Jaarsma D., Van Der Pluijm I., De Waard M.C., et al. Age-Related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology. PLoS Genet. 2011;7 doi: 10.1371/journal.pgen.1002405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Yune T.Y., Lee J.Y., Jung G.Y., et al. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 2007;27:7751–7761. doi: 10.1523/JNEUROSCI.1661-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Pang Y., Campbell L., Zheng B., et al. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience. 2010;166:464–475. doi: 10.1016/j.neuroscience.2009.12.040. [DOI] [PubMed] [Google Scholar]
  • 169.Fahnestock M., Yu G., Coughlin M.D. ProNGF: a neurotrophic or an apoptotic molecule? Prog. Brain Res. 2004;146:101–110. doi: 10.1016/S0079-6123(03)46007-X. [DOI] [PubMed] [Google Scholar]
  • 170.Mohamed R., El-Remessy A.B. Imbalance of the nerve growth factor and its precursor: implication in diabetic retinopathy. J. Clin. Exp. Ophthalmol. 2015;6 doi: 10.4172/2155-9570.1000483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Ioannou M.S., Fahnestock M. ProNGF, but Not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrkA receptor levels. Int. J. Mol. Sci. 2017;18 doi: 10.3390/ijms18030599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Fukushima S., Furube E., Itoh M., et al. Robust increase of microglia proliferation in the fornix of hippocampal axonal pathway after a single LPS stimulation. J. Neuroimmunol. 2015;285:31–40. doi: 10.1016/J.JNEUROIM.2015.05.014. [DOI] [PubMed] [Google Scholar]
  • 173.Mohamed R., Shanab A.Y., El Remessy A.B. Deletion of the neurotrophin receptor p75NTR prevents diabetes-induced retinal acellular capillaries in streptozotocin-induced mouse diabetic model. J. Diabetes Metab. Disord. Control. 2017;4 doi: 10.15406/jdmdc.2017.04.00129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Dechant G., Barde Y.A. The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat. Neurosci. 2002;5:1131–1136. doi: 10.1038/nn1102-1131. [DOI] [PubMed] [Google Scholar]
  • 175.Perlson E., Maday S., meng Fu M, et al. Retrograde axonal transport: pathways to cell death? Trends Neurosci. 2010 doi: 10.1016/j.tins.2010.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cerebral Circulation - Cognition and Behavior are provided here courtesy of Elsevier

RESOURCES